PNTG — The Pennant Group Inc. Common Stock stock price and chart

PNTG

$41.48+2.02%

as of close, Oct 20, 2026

☾ AH $41.48 +2.02%

The Pennant Group Inc. Common StockStock · HealthcareRussell 2000 · 0.04% of IWMUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV

PeersENSGSPYQQQNVDAAAPLMSFT

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Oct 4, 2019

VolumeEEEEEEEEEEEE

20192021202320252026

10.020.030.040.050.060.005.0M$41.48

2026-10-20

Price$41.48

MA20$39.66

MA50$35.15

Vol287.1K

What would $1,000 invested in PNTG be worth today? →

PNTG returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $41.48
YTD price return: +47.35%
YTD total return: +47.35%
Next earnings: Nov 4, 2026
Market cap: 1.4B2019-12 922.2M2026-10 1.4B+57.1% over the window
Enterprise value: 2B
Shares outstanding: 34.9M2017-12 27.8M2026-06 34.9M+25.5% over the window
52W low: $22.26
52W high: $42.74
From 52W high: -2.95%
From 52W low: +86.39%
52W range: 94%

Volume

Rel volume: 0.75×
30D volume: 381.3K
30D $ vol: 15.4M

Fundamentals

Sales (ttm): 1.1B2017-12 251M2026-06 1.1B+338.9% over the window
Sales/share: $31.542017-12 $9.022026-06 $31.54+249.8% over the window
EPS (ttm): $0.912017-12 $0.362026-06 $0.91+152.1% over the window
FCF (ttm): 34.7M2017-12 14.1M2026-06 34.7M+145.7% over the window
FCF/share: $0.992017-12 $0.512026-06 $0.99+95.8% over the window
Book value/share: $11.582017-12 $2.152026-06 $11.58+437.9% over the window
Net margin: 2.93%2017-12 3.9%2026-06 2.9%-25.4% over the window
ROE: 7.99%2017-12 16.5%2026-06 8.0%-51.5% over the window
ROA: 3.12%2018-12 16.0%2026-06 3.1%-80.5% over the window
Debt / equity: 0.48×2018-12 0.002026-06 0.48
Current ratio: 1.202018-12 0.992026-06 1.20+22.2% over the window

Growth (CAGR, ttm) · 10Y

Sales: +37.93%2025-06-30 → 2026-06-30798.9M → 1.1B (+37.9% total)+29.97%2023-06-30 → 2026-06-30501.8M → 1.1B (+119.6% total)+21.14%2021-06-30 → 2026-06-30422.4M → 1.1B (+160.8% total)n/a
Net income: +20.51%2025-06-30 → 2026-06-3026.8M → 32.3M (+20.5% total)+35.63%2023-06-30 → 2026-06-3013M → 32.3M (+149.5% total)+21.86%2021-06-30 → 2026-06-3012M → 32.3M (+168.7% total)n/a
FCF: +6.98%2025-06-30 → 2026-06-3032.4M → 34.7M (+7.0% total)+54.52%2023-06-30 → 2026-06-309.4M → 34.7M (+269.1% total)n/an/a
Shares: +1.06%2025-06-30 → 2026-06-3034.6M → 34.9M (+1.1% total)+5.38%2023-06-30 → 2026-06-3029.9M → 34.9M (+17.0% total)+4.25%2021-06-30 → 2026-06-3028.4M → 34.9M (+23.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +16.19%2025-06-30 → 2026-06-30$0.78 → $0.91 (+16.2% total)+28.31%2023-06-30 → 2026-06-30$0.43 → $0.91 (+111.3% total)+18.31%2021-06-30 → 2026-06-30$0.39 → $0.91 (+131.8% total)n/a
Sales/share: +36.48%2025-06-30 → 2026-06-30$23.12 → $31.54 (+36.5% total)+23.34%2023-06-30 → 2026-06-30$16.81 → $31.54 (+87.6% total)+16.20%2021-06-30 → 2026-06-30$14.89 → $31.54 (+111.8% total)n/a
FCF/share: +5.86%2025-06-30 → 2026-06-30$0.94 → $0.99 (+5.9% total)+46.64%2023-06-30 → 2026-06-30$0.31 → $0.99 (+215.4% total)n/an/a
Book value/share: +19.97%2025-06-30 → 2026-06-30$9.65 → $11.58 (+20.0% total)+37.24%2023-06-30 → 2026-06-30$4.48 → $11.58 (+158.5% total)+24.46%2021-06-30 → 2026-06-30$3.88 → $11.58 (+198.6% total)n/a
Price: +72.90%2025-10-20 → 2026-10-20$24.00 → $41.48 (+72.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+55.03%2023-10-20 → 2026-10-20$11.13 → $41.48 (+272.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+12.07%2021-10-20 → 2026-10-20$23.47 → $41.48 (+76.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +72.90%2025-10-20 → 2026-10-20$24.00 → $41.48 (+72.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+55.03%2023-10-20 → 2026-10-20$11.13 → $41.48 (+272.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.07%2021-10-20 → 2026-10-20$23.47 → $41.48 (+76.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 45.7×2019-12 362.202026-10 44.83-87.6% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 23.3×2019-12 162.642026-10 23.30-85.7% over the window
Fwd P/E: 25.6×
P/S (ttm)Market cap ÷ TTM revenue.: 1.3×2019-12 2.722026-10 1.32-51.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.6×2019-12 12.972026-10 3.58-72.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 41.8×2019-12 324.712026-10 41.77-87.1% over the window
EV/EBITDA (fy): 27.3×
EV/Sales (ttm): 1.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 2.39%2019-09 1.5%2026-06 2.7%+76.6% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 34.9M ÷ 34.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.06%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.06%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.06%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2019-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.4B). Same caveat as the cash buyback yield.: 0.00%2019-09 0.0%2026-06 0.0%

Vs own 10Y history

P/E: 42nd
P/OI: 36th
P/S: 60th
P/B: 48th
P/FCF: 67th

Bar = where today’s multiple sits in PNTG’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.02%

+3.31%

+4.69%

+0.80%

YTD

+47.35%

+72.83%

+76.74%

Financial statements

Open full PNTG financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

PNTG — The Pennant Group Inc. Common Stock price, chart and key statistics